Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Tassanai Intravooth"'
Publikováno v:
Epilepsia Open, Vol 9, Iss 4, Pp 1502-1514 (2024)
Abstract Objective In Europe, cenobamate has been approved for use as an adjunctive therapy in adult patients with epilepsy (PWE) with focal‐onset seizures (FOS) who have not responded satisfactorily to treatment with at least two antiseizure medic
Externí odkaz:
https://doaj.org/article/9faeda2f9e984908b6dde622241661a0
Autor:
Max J Hilz, Tassanai Intravooth, Sebastian Moeller, Ruihao Wang, De-Hyung Lee, Julia Koehn, Ralf A Linker
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132139 (2015)
In multiple sclerosis (MS) patients, Fingolimod may induce prolonged heart-rate slowing which might be caused by MS-related central autonomic lesions.To evaluate whether MS-patients with prolonged heart-rate slowing (> six hours) upon Fingolimod show
Externí odkaz:
https://doaj.org/article/10271a83598e4abbb144cf98a0e67295
Publikováno v:
Clinical Epileptology. 36:45-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::610cd250689263c98a145bf5a5dee319
https://doi.org/10.1007/s10309-023-00567-3
https://doi.org/10.1007/s10309-023-00567-3
Autor:
Jakob Stockinger, Anke M. Staack, Bernhard J. Steinhoff, Christoph Kurth, Tassanai Intravooth
Publikováno v:
Zeitschrift für Epileptologie. 34:98-101
Wir berichten uber einen jungen Patienten mit einer seltenen Form einer progressiven Myoklonusepilepsie. Der langwierige Weg zur richtigen Diagnose, der unterem anderem durch die Ergebnisse der somatosensibel evozierten Potenziale (SEP) entscheidend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de736dab20c23003309b26b309336c79
https://doi.org/10.1007/s10309-020-00369-x
https://doi.org/10.1007/s10309-020-00369-x
Autor:
Michal Cicanic, Jakob Stockinger, Bernhard J. Steinhoff, Tassanai Intravooth, Andrea Nemecek, Adam Strzelczyk, Hajo M. Hamer, Christian Brandt, Frank Bösebeck
Publikováno v:
EpilepsiaREFERENCES. 62(3)
Objective There is evidence that everolimus (EVE) significantly reduces seizure frequency in epilepsy patients with tuberous sclerosis complex (TSC). Given that TSC-related proliferative processes are more dynamic during brain development, seizure ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e3f1781ec3eeaa6886f8728410df5a
https://pubmed.ncbi.nlm.nih.gov/33534134
https://pubmed.ncbi.nlm.nih.gov/33534134
Publikováno v:
Seizure. 83
Although levetiracetam (LEV) is globally established as a leading antiseizure medication (ASM) it is still a controversial matter whether dose increases correspond with an increased efficacy if LEV in the recommended dose range did not show satisfyin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a78c234677832d3fb15ca68dae339e75
https://pubmed.ncbi.nlm.nih.gov/33197757
https://pubmed.ncbi.nlm.nih.gov/33197757
Autor:
Reinhold Kornmeier, Jakob Stockinger, Bernhard J. Steinhoff, Matthias Bacher, Christoph Kurth, Iancu Bucurenciu, Anke M. Staack, Barbara Hillenbrand, Tassanai Intravooth
Publikováno v:
Seizure. 48:11-14
Purpose To assess the efficiency of brivaracetam under real-world conditions in a tertiary referral epilepsy center. Methods We consecutively collected patients treated at our center with brivaracetam (BRV). After a minimum observation period of six
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41700b1a334cb2b615278f88521d54a
https://doi.org/10.1016/j.seizure.2017.03.010
https://doi.org/10.1016/j.seizure.2017.03.010
Autor:
Bernhard J. Steinhoff, Marko Blickhan, Patricia Mahn, Jakob Stockinger, Reinhold Kornmeier, Anke M. Staack, Daniel Dietmann, Matthias Bacher, Matthias Schneider, Viviane Bernedo, Tassanai Intravooth, Christoph Kurth
Publikováno v:
Epilepsy research. 159
Brivaracetam (BRV) was recently introduced for the treatment of patients with focal epilepsy. BRV undergoes relatively few interactions, but one of them leads to the elevation of carbamazepine (CBZ)-10,11-CBZ-epoxide (CBZ-E) if BRV is co-administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d4346b60e1c7b2aec739a57c7eac4b
https://pubmed.ncbi.nlm.nih.gov/31743818
https://pubmed.ncbi.nlm.nih.gov/31743818
Autor:
Bernhard Oehl, Anne-Sophie Wendling, Artur Tanezer, Bernhard J. Steinhoff, Tassanai Intravooth, Anke M. Staack, Jakob Stockinger
Publikováno v:
Epilepsy & Behavior. 112:107408
Seizure manifestations may be difficult to describe in words alone. Thus, initially, 24 seizure images were developed to support communication and gain assistance during obtaining the patient's history. Before being used in clinical practice, these s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d32a6d1e7aba4cde857acf899e1c0946
https://doi.org/10.1016/j.yebeh.2020.107408
https://doi.org/10.1016/j.yebeh.2020.107408
Autor:
Jakob Stockinger, Anke M. Staack, Bernhard J. Steinhoff, Tassanai Intravooth, Katharina Juerges
Publikováno v:
Epilepsy research. 143
Recent evidence suggests that eslicarbazepine acetate (ESL) might be an appropriate alternative to carbamazepine (CBZ) and oxcarbazepine (OXC) due to its better safety profile. Hyponatremia may be one of the limiting safety problems in CBZ and OXC wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6a64222152a34c9628bd18f6993e57
https://pubmed.ncbi.nlm.nih.gov/29631131
https://pubmed.ncbi.nlm.nih.gov/29631131